COVID-19 Impact on Global Oral Rotavirus Vaccine, Market Insights and Forecast to 2026
- BMR3903711
- 114 Pages
- June 2020
- Healthcare
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Oral Rotavirus Vaccine industry.
Based on our recent survey, we have several different scenarios about the Oral Rotavirus Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Oral Rotavirus Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oral Rotavirus Vaccine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oral Rotavirus Vaccine market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Oral Rotavirus Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Oral Rotavirus Vaccine market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Oral Rotavirus Vaccine market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Oral Rotavirus Vaccine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oral Rotavirus Vaccine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oral Rotavirus Vaccine market.
The following manufacturers are covered in this report:
GSK
Sanofi-Pasteur
Merck
Biological E. Limited
China National Biotec Group
Sinovac Biotech
...
Oral Rotavirus Vaccine Breakdown Data by Type
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Oral Rotavirus Vaccine Breakdown Data by Application
Hospital
Vaccination Station
Other
1.1 Oral Rotavirus Vaccine Product Introduction
1.2 Market Segments
1.3 Key Oral Rotavirus Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oral Rotavirus Vaccine Market Size Growth Rate by Type
1.4.2 Rotarix
1.4.3 RotaTeq
1.4.4 Rotavac
1.4.5 Rotavin-M1
1.4.6 Lanzhou lamb
1.5 Market by Application
1.5.1 Global Oral Rotavirus Vaccine Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Vaccination Station
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Oral Rotavirus Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the Oral Rotavirus Vaccine Industry
1.6.1.1 Oral Rotavirus Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Oral Rotavirus Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Oral Rotavirus Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Oral Rotavirus Vaccine Market Size Estimates and Forecasts
2.1.1 Global Oral Rotavirus Vaccine Revenue 2015-2026
2.1.2 Global Oral Rotavirus Vaccine Sales 2015-2026
2.2 Oral Rotavirus Vaccine Market Size by Region: 2020 Versus 2026
2.2.1 Global Oral Rotavirus Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oral Rotavirus Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oral Rotavirus Vaccine Competitor Landscape by Players
3.1 Oral Rotavirus Vaccine Sales by Manufacturers
3.1.1 Oral Rotavirus Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Oral Rotavirus Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Oral Rotavirus Vaccine Revenue by Manufacturers
3.2.1 Oral Rotavirus Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Oral Rotavirus Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oral Rotavirus Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oral Rotavirus Vaccine Revenue in 2019
3.2.5 Global Oral Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oral Rotavirus Vaccine Price by Manufacturers
3.4 Oral Rotavirus Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Oral Rotavirus Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Rotavirus Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Oral Rotavirus Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Oral Rotavirus Vaccine Market Size by Type (2015-2020)
4.1.1 Global Oral Rotavirus Vaccine Sales by Type (2015-2020)
4.1.2 Global Oral Rotavirus Vaccine Revenue by Type (2015-2020)
4.1.3 Oral Rotavirus Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oral Rotavirus Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Oral Rotavirus Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Oral Rotavirus Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Oral Rotavirus Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oral Rotavirus Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Oral Rotavirus Vaccine Market Size by Application (2015-2020)
5.1.1 Global Oral Rotavirus Vaccine Sales by Application (2015-2020)
5.1.2 Global Oral Rotavirus Vaccine Revenue by Application (2015-2020)
5.1.3 Oral Rotavirus Vaccine Price by Application (2015-2020)
5.2 Oral Rotavirus Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Oral Rotavirus Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Oral Rotavirus Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Oral Rotavirus Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Oral Rotavirus Vaccine by Country
6.1.1 North America Oral Rotavirus Vaccine Sales by Country
6.1.2 North America Oral Rotavirus Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oral Rotavirus Vaccine Market Facts & Figures by Type
6.3 North America Oral Rotavirus Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Oral Rotavirus Vaccine by Country
7.1.1 Europe Oral Rotavirus Vaccine Sales by Country
7.1.2 Europe Oral Rotavirus Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oral Rotavirus Vaccine Market Facts & Figures by Type
7.3 Europe Oral Rotavirus Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Oral Rotavirus Vaccine by Region
8.1.1 Asia Pacific Oral Rotavirus Vaccine Sales by Region
8.1.2 Asia Pacific Oral Rotavirus Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oral Rotavirus Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Oral Rotavirus Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Oral Rotavirus Vaccine by Country
9.1.1 Latin America Oral Rotavirus Vaccine Sales by Country
9.1.2 Latin America Oral Rotavirus Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oral Rotavirus Vaccine Market Facts & Figures by Type
9.3 Central & South America Oral Rotavirus Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Oral Rotavirus Vaccine by Country
10.1.1 Middle East and Africa Oral Rotavirus Vaccine Sales by Country
10.1.2 Middle East and Africa Oral Rotavirus Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oral Rotavirus Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Oral Rotavirus Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description, Business Overview and Total Revenue
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Oral Rotavirus Vaccine Products Offered
11.1.5 GSK Recent Development
11.2 Sanofi-Pasteur
11.2.1 Sanofi-Pasteur Corporation Information
11.2.2 Sanofi-Pasteur Description, Business Overview and Total Revenue
11.2.3 Sanofi-Pasteur Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi-Pasteur Oral Rotavirus Vaccine Products Offered
11.2.5 Sanofi-Pasteur Recent Development
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description, Business Overview and Total Revenue
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Oral Rotavirus Vaccine Products Offered
11.3.5 Merck Recent Development
11.4 Biological E. Limited
11.4.1 Biological E. Limited Corporation Information
11.4.2 Biological E. Limited Description, Business Overview and Total Revenue
11.4.3 Biological E. Limited Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Biological E. Limited Oral Rotavirus Vaccine Products Offered
11.4.5 Biological E. Limited Recent Development
11.5 China National Biotec Group
11.5.1 China National Biotec Group Corporation Information
11.5.2 China National Biotec Group Description, Business Overview and Total Revenue
11.5.3 China National Biotec Group Sales, Revenue and Gross Margin (2015-2020)
11.5.4 China National Biotec Group Oral Rotavirus Vaccine Products Offered
11.5.5 China National Biotec Group Recent Development
11.6 Sinovac Biotech
11.6.1 Sinovac Biotech Corporation Information
11.6.2 Sinovac Biotech Description, Business Overview and Total Revenue
11.6.3 Sinovac Biotech Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sinovac Biotech Oral Rotavirus Vaccine Products Offered
11.6.5 Sinovac Biotech Recent Development
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description, Business Overview and Total Revenue
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Oral Rotavirus Vaccine Products Offered
11.1.5 GSK Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Oral Rotavirus Vaccine Market Estimates and Projections by Region
12.1.1 Global Oral Rotavirus Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Oral Rotavirus Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Oral Rotavirus Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Oral Rotavirus Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Oral Rotavirus Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Oral Rotavirus Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Oral Rotavirus Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Oral Rotavirus Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Oral Rotavirus Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Oral Rotavirus Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oral Rotavirus Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oral Rotavirus Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oral Rotavirus Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oral Rotavirus Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Oral Rotavirus Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Oral Rotavirus Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Oral Rotavirus Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Oral Rotavirus Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oral Rotavirus Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oral Rotavirus Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oral Rotavirus Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oral Rotavirus Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oral Rotavirus Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral Rotavirus Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
Table 1. Oral Rotavirus Vaccine Market Segments
Table 2. Ranking of Global Top Oral Rotavirus Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oral Rotavirus Vaccine Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Rotarix
Table 5. Major Manufacturers of RotaTeq
Table 6. Major Manufacturers of Rotavac
Table 7. Major Manufacturers of Rotavin-M1
Table 8. Major Manufacturers of Lanzhou lamb
Table 9. COVID-19 Impact Global Market: (Four Oral Rotavirus Vaccine Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Oral Rotavirus Vaccine Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Oral Rotavirus Vaccine Players to Combat Covid-19 Impact
Table 14. Global Oral Rotavirus Vaccine Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 15. Global Oral Rotavirus Vaccine Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 16. Global Oral Rotavirus Vaccine Sales by Regions 2015-2020 (K Pcs)
Table 17. Global Oral Rotavirus Vaccine Sales Market Share by Regions (2015-2020)
Table 18. Global Oral Rotavirus Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Oral Rotavirus Vaccine Sales by Manufacturers (2015-2020) (K Pcs)
Table 20. Global Oral Rotavirus Vaccine Sales Share by Manufacturers (2015-2020)
Table 21. Global Oral Rotavirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Oral Rotavirus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Rotavirus Vaccine as of 2019)
Table 23. Oral Rotavirus Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Oral Rotavirus Vaccine Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Oral Rotavirus Vaccine Price (2015-2020) (USD/Pcs)
Table 26. Oral Rotavirus Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Oral Rotavirus Vaccine Product Type
Table 28. Date of International Manufacturers Enter into Oral Rotavirus Vaccine Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Oral Rotavirus Vaccine Sales by Type (2015-2020) (K Pcs)
Table 31. Global Oral Rotavirus Vaccine Sales Share by Type (2015-2020)
Table 32. Global Oral Rotavirus Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Oral Rotavirus Vaccine Revenue Share by Type (2015-2020)
Table 34. Oral Rotavirus Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 35. Global Oral Rotavirus Vaccine Sales by Application (2015-2020) (K Pcs)
Table 36. Global Oral Rotavirus Vaccine Sales Share by Application (2015-2020)
Table 37. North America Oral Rotavirus Vaccine Sales by Country (2015-2020) (K Pcs)
Table 38. North America Oral Rotavirus Vaccine Sales Market Share by Country (2015-2020)
Table 39. North America Oral Rotavirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Oral Rotavirus Vaccine Revenue Market Share by Country (2015-2020)
Table 41. North America Oral Rotavirus Vaccine Sales by Type (2015-2020) (K Pcs)
Table 42. North America Oral Rotavirus Vaccine Sales Market Share by Type (2015-2020)
Table 43. North America Oral Rotavirus Vaccine Sales by Application (2015-2020) (K Pcs)
Table 44. North America Oral Rotavirus Vaccine Sales Market Share by Application (2015-2020)
Table 45. Europe Oral Rotavirus Vaccine Sales by Country (2015-2020) (K Pcs)
Table 46. Europe Oral Rotavirus Vaccine Sales Market Share by Country (2015-2020)
Table 47. Europe Oral Rotavirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Oral Rotavirus Vaccine Revenue Market Share by Country (2015-2020)
Table 49. Europe Oral Rotavirus Vaccine Sales by Type (2015-2020) (K Pcs)
Table 50. Europe Oral Rotavirus Vaccine Sales Market Share by Type (2015-2020)
Table 51. Europe Oral Rotavirus Vaccine Sales by Application (2015-2020) (K Pcs)
Table 52. Europe Oral Rotavirus Vaccine Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Oral Rotavirus Vaccine Sales by Region (2015-2020) (K Pcs)
Table 54. Asia Pacific Oral Rotavirus Vaccine Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Oral Rotavirus Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Oral Rotavirus Vaccine Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Oral Rotavirus Vaccine Sales by Type (2015-2020) (K Pcs)
Table 58. Asia Pacific Oral Rotavirus Vaccine Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Oral Rotavirus Vaccine Sales by Application (2015-2020) (K Pcs)
Table 60. Asia Pacific Oral Rotavirus Vaccine Sales Market Share by Application (2015-2020)
Table 61. Latin America Oral Rotavirus Vaccine Sales by Country (2015-2020) (K Pcs)
Table 62. Latin America Oral Rotavirus Vaccine Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Oral Rotavirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Oral Rotavirus Vaccine Revenue Market Share by Country (2015-2020)
Table 65. Latin America Oral Rotavirus Vaccine Sales by Type (2015-2020) (K Pcs)
Table 66. Latin America Oral Rotavirus Vaccine Sales Market Share by Type (2015-2020)
Table 67. Latin America Oral Rotavirus Vaccine Sales by Application (2015-2020) (K Pcs)
Table 68. Latin America Oral Rotavirus Vaccine Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Oral Rotavirus Vaccine Sales by Country (2015-2020) (K Pcs)
Table 70. Middle East and Africa Oral Rotavirus Vaccine Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Oral Rotavirus Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Oral Rotavirus Vaccine Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Oral Rotavirus Vaccine Sales by Type (2015-2020) (K Pcs)
Table 74. Middle East and Africa Oral Rotavirus Vaccine Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Oral Rotavirus Vaccine Sales by Application (2015-2020) (K Pcs)
Table 76. Middle East and Africa Oral Rotavirus Vaccine Sales Market Share by Application (2015-2020)
Table 77. GSK Corporation Information
Table 78. GSK Description and Major Businesses
Table 79. GSK Oral Rotavirus Vaccine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. GSK Product
Table 81. GSK Recent Development
Table 82. Sanofi-Pasteur Corporation Information
Table 83. Sanofi-Pasteur Description and Major Businesses
Table 84. Sanofi-Pasteur Oral Rotavirus Vaccine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Sanofi-Pasteur Product
Table 86. Sanofi-Pasteur Recent Development
Table 87. Merck Corporation Information
Table 88. Merck Description and Major Businesses
Table 89. Merck Oral Rotavirus Vaccine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Merck Product
Table 91. Merck Recent Development
Table 92. Biological E. Limited Corporation Information
Table 93. Biological E. Limited Description and Major Businesses
Table 94. Biological E. Limited Oral Rotavirus Vaccine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Biological E. Limited Product
Table 96. Biological E. Limited Recent Development
Table 97. China National Biotec Group Corporation Information
Table 98. China National Biotec Group Description and Major Businesses
Table 99. China National Biotec Group Oral Rotavirus Vaccine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. China National Biotec Group Product
Table 101. China National Biotec Group Recent Development
Table 102. Sinovac Biotech Corporation Information
Table 103. Sinovac Biotech Description and Major Businesses
Table 104. Sinovac Biotech Oral Rotavirus Vaccine Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Sinovac Biotech Product
Table 106. Sinovac Biotech Recent Development
Table 107. Global Oral Rotavirus Vaccine Sales Forecast by Regions (2021-2026) (K Pcs)
Table 108. Global Oral Rotavirus Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 109. Global Oral Rotavirus Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 110. Global Oral Rotavirus Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 111. North America: Oral Rotavirus Vaccine Sales Forecast by Country (2021-2026) (K Pcs)
Table 112. North America: Oral Rotavirus Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Europe: Oral Rotavirus Vaccine Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Europe: Oral Rotavirus Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Asia Pacific: Oral Rotavirus Vaccine Sales Forecast by Region (2021-2026) (K Pcs)
Table 116. Asia Pacific: Oral Rotavirus Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 117. Latin America: Oral Rotavirus Vaccine Sales Forecast by Country (2021-2026) (K Pcs)
Table 118. Latin America: Oral Rotavirus Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Middle East and Africa: Oral Rotavirus Vaccine Sales Forecast by Country (2021-2026) (K Pcs)
Table 120. Middle East and Africa: Oral Rotavirus Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 122. Key Challenges
Table 123. Market Risks
Table 124. Main Points Interviewed from Key Oral Rotavirus Vaccine Players
Table 125. Oral Rotavirus Vaccine Customers List
Table 126. Oral Rotavirus Vaccine Distributors List
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Rotavirus Vaccine Product Picture
Figure 2. Global Oral Rotavirus Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Rotarix Product Picture
Figure 4. RotaTeq Product Picture
Figure 5. Rotavac Product Picture
Figure 6. Rotavin-M1 Product Picture
Figure 7. Lanzhou lamb Product Picture
Figure 8. Global Oral Rotavirus Vaccine Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Vaccination Station
Figure 11. Other
Figure 12. Oral Rotavirus Vaccine Report Years Considered
Figure 13. Global Oral Rotavirus Vaccine Market Size 2015-2026 (US$ Million)
Figure 14. Global Oral Rotavirus Vaccine Sales 2015-2026 (K Pcs)
Figure 15. Global Oral Rotavirus Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Oral Rotavirus Vaccine Sales Market Share by Region (2015-2020)
Figure 17. Global Oral Rotavirus Vaccine Sales Market Share by Region in 2019
Figure 18. Global Oral Rotavirus Vaccine Revenue Market Share by Region (2015-2020)
Figure 19. Global Oral Rotavirus Vaccine Revenue Market Share by Region in 2019
Figure 20. Global Oral Rotavirus Vaccine Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Oral Rotavirus Vaccine Revenue in 2019
Figure 22. Oral Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Oral Rotavirus Vaccine Sales Market Share by Type (2015-2020)
Figure 24. Global Oral Rotavirus Vaccine Sales Market Share by Type in 2019
Figure 25. Global Oral Rotavirus Vaccine Revenue Market Share by Type (2015-2020)
Figure 26. Global Oral Rotavirus Vaccine Revenue Market Share by Type in 2019
Figure 27. Global Oral Rotavirus Vaccine Market Share by Price Range (2015-2020)
Figure 28. Global Oral Rotavirus Vaccine Sales Market Share by Application (2015-2020)
Figure 29. Global Oral Rotavirus Vaccine Sales Market Share by Application in 2019
Figure 30. Global Oral Rotavirus Vaccine Revenue Market Share by Application (2015-2020)
Figure 31. Global Oral Rotavirus Vaccine Revenue Market Share by Application in 2019
Figure 32. North America Oral Rotavirus Vaccine Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Oral Rotavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Oral Rotavirus Vaccine Sales Market Share by Country in 2019
Figure 35. North America Oral Rotavirus Vaccine Revenue Market Share by Country in 2019
Figure 36. U.S. Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Oral Rotavirus Vaccine Market Share by Type in 2019
Figure 41. North America Oral Rotavirus Vaccine Market Share by Application in 2019
Figure 42. Europe Oral Rotavirus Vaccine Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Oral Rotavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Oral Rotavirus Vaccine Sales Market Share by Country in 2019
Figure 45. Europe Oral Rotavirus Vaccine Revenue Market Share by Country in 2019
Figure 46. Germany Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Oral Rotavirus Vaccine Market Share by Type in 2019
Figure 57. Europe Oral Rotavirus Vaccine Market Share by Application in 2019
Figure 58. Asia Pacific Oral Rotavirus Vaccine Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Oral Rotavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Oral Rotavirus Vaccine Sales Market Share by Region in 2019
Figure 61. Asia Pacific Oral Rotavirus Vaccine Revenue Market Share by Region in 2019
Figure 62. China Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Oral Rotavirus Vaccine Market Share by Type in 2019
Figure 85. Asia Pacific Oral Rotavirus Vaccine Market Share by Application in 2019
Figure 86. Latin America Oral Rotavirus Vaccine Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Oral Rotavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Oral Rotavirus Vaccine Sales Market Share by Country in 2019
Figure 89. Latin America Oral Rotavirus Vaccine Revenue Market Share by Country in 2019
Figure 90. Mexico Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Oral Rotavirus Vaccine Market Share by Type in 2019
Figure 97. Latin America Oral Rotavirus Vaccine Market Share by Application in 2019
Figure 98. Middle East and Africa Oral Rotavirus Vaccine Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Oral Rotavirus Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Oral Rotavirus Vaccine Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Oral Rotavirus Vaccine Revenue Market Share by Country in 2019
Figure 102. Turkey Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Oral Rotavirus Vaccine Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Oral Rotavirus Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Oral Rotavirus Vaccine Market Share by Type in 2019
Figure 109. Middle East and Africa Oral Rotavirus Vaccine Market Share by Application in 2019
Figure 110. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Sanofi-Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Biological E. Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. China National Biotec Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Sinovac Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Oral Rotavirus Vaccine Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. North America Oral Rotavirus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Oral Rotavirus Vaccine Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Europe Oral Rotavirus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Oral Rotavirus Vaccine Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Asia Pacific Oral Rotavirus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Oral Rotavirus Vaccine Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 123. Latin America Oral Rotavirus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Oral Rotavirus Vaccine Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 125. Middle East and Africa Oral Rotavirus Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
Licenses Type
USD 3,900 Single License
USD 7,800 Enterprise License
BUY NOW Add to Cart
Why QYR
Fastest report delivery service
More than 10 years of vast experience
Operational for 24 * 7 & 365 days
In-depth and comprehensive analysis
Excellent after sales support
Owns large database
Need Help ?
Email Us FAQ
COVID 19 Impact on Global Oral Rotavirus Vaccine market
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
